» Articles » PMID: 14572536

Persistence of Antibiotic Resistant Bacteria

Overview
Specialty Microbiology
Date 2003 Oct 24
PMID 14572536
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

Bacterial adaptation to antibiotics has been very successful and over the past decade the increase in antibiotic resistance has generated considerable medical problems. Even though many drug resistances confer a fitness cost, suggesting that they might disappear by reducing the volume of antibiotic use, increasing evidence obtained from laboratory and epidemiological studies indicate that several processes will act to cause long-term persistence of resistant bacteria. Compensatory evolution that ameliorates the costs of resistance, the occurrence of cost-free resistances and genetic linkage between non-selected and selected resistances will confer a stabilization of the resistant bacteria. Thus, it is of importance that we forcefully implement strategies to reduce the rate of appearance and spread of resistant bacteria to allow new drug discovery to catch up with bacterial resistance development.

Citing Articles

Assessing fitness costs in malaria parasites: a comprehensive review and implications for drug resistance management.

Segovia X, Srivastava B, Serrato-Arroyo S, Guerrero A, Huijben S Malar J. 2025; 24(1):65.

PMID: 40025552 PMC: 11871665. DOI: 10.1186/s12936-025-05286-w.


Antimicrobial resistance in fish and poultry: Public health implications for animal source food production in Nigeria, Egypt, and South Africa.

Okon E, Okocha R, Adesina B, Ehigie J, Alabi O, Bolanle A Front Antibiot. 2025; 1():1043302.

PMID: 39816413 PMC: 11732016. DOI: 10.3389/frabi.2022.1043302.


Comparison of Plasmid Curing Efficiency across Five Lactic Acid Bacterial Species.

Park C, Yang H, Kim S, Yun C, Jang B, Hong Y J Microbiol Biotechnol. 2024; 34(11):2385-2395.

PMID: 39403731 PMC: 11637826. DOI: 10.4014/jmb.2406.06003.


A Profile of Drug-Resistant Mutations in Isolates from Guangdong Province, China.

Zhang C, Wu Z, Huang X, Zhao Y, Sun Q, Chen Y Indian J Microbiol. 2024; 64(3):1044-1056.

PMID: 39282200 PMC: 11399372. DOI: 10.1007/s12088-024-01236-3.


Vancomycin-resistant Staphylococcus aureus (VRSA) can overcome the cost of antibiotic resistance and may threaten vancomycin's clinical durability.

Blechman S, Wright E PLoS Pathog. 2024; 20(8):e1012422.

PMID: 39207957 PMC: 11361437. DOI: 10.1371/journal.ppat.1012422.